Get started
Work

P1.14-25 Targeting NRG1-Fusions in Lung Adenocarcinoma: Afatinib as a Novel Potential Treatment Strategy

Year: 2019
Type: article
DOI: 10.1016/j.jtho.2019.08.1176
Authors: M. Duruisseaux, J.J. Laskin, K. Tolba, E. Brandén, Y. Goto, R. Doebele, P.K. Cheema, J. Cadranel, M.R. Jones, A. Drilon, D. Trombetta, L.A. Muscarella, A. Cseh, F. Solca, S. Liu
Institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, University of British Columbia, Oregon Health & Science University, Gävle Hospital, National Cancer Center Hospital, University of Colorado Cancer Center, University of Toronto, William Osler Health System, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Tenon, Qiagen (United States), Memorial Sloan Kettering Cancer Center, Casa Sollievo della Sofferenza, Boehringer Ingelheim (Austria), Georgetown University
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2982104988
FWCI: 0.371
Cites:
Cited by: 3
Related to: 10